Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan M Kaech

Showing results (151-160 of 175) with videos related to

Pageof 18
Sort By:
Cell|May 16, 2024
ARID1A suppresses R-loop-mediated STING-type I interferon pathway activation of anti-tumor immunityMatthew B Maxwell, Marianne S Hom-Tedla, Jawoon Yi, et al.
Nature Communications|February 17, 2019
A functional subset of CD8<sup>+</sup> T cells during chronic exhaustion is defined by SIRPα expressionLara M Myers, Michal Caspi Tal, Laughing Bear Torrez Dulgeroff, et al.
Science (New York, N.Y.)|September 21, 2023
Manipulating mitochondrial electron flow enhances tumor immunogenicityKailash Chandra Mangalhara, Siva Karthik Varanasi, Melissa A Johnson, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 15, 2011
Natural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8+ T-cell immunityPhilipp A Lang, Karl S Lang, Haifeng C Xu, et al.
Cell|February 10, 2015
Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetesRachel J Perry, João-Paulo G Camporez, Romy Kursawe, et al.
Cell Metabolism|January 4, 2023
Immunoediting instructs tumor metabolic reprogramming to support immune evasionChin-Hsien Tsai, Yu-Ming Chuang, Xiaoyun Li, et al.
Cancer Discovery|October 14, 2017
Impaired HLA Class I Antigen Processing and Presentation as a Mechanism of Acquired Resistance to Immune Checkpoint Inhibitors in Lung CancerScott Gettinger, Jungmin Choi, Katherine Hastings, et al.
Cell|September 10, 2019
Proteomics of Melanoma Response to Immunotherapy Reveals Mitochondrial DependenceMichal Harel, Rona Ortenberg, Siva Karthik Varanasi, et al.
Developmental Cell|November 11, 2021
1-deoxysphingolipids bind to COUP-TF to modulate lymphatic and cardiac cell developmentTing Wang, Zheng Wang, Lauriane de Fabritus, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 18, 2025
EVOLVE platform, a trispecific T cell engager with integrated CD2 costimulation, for the treatment of solid and hematologic tumorsOksana A Sergeeva, Guixian Jin, Mohosin Sarkar, et al.
Pageof 18

Showing results (151-160 of 175) with videos related to

Sort By:
Pageof 18
Cell|May 16, 2024
ARID1A suppresses R-loop-mediated STING-type I interferon pathway activation of anti-tumor immunityMatthew B Maxwell, Marianne S Hom-Tedla, Jawoon Yi, et al.
Nature Communications|February 17, 2019
A functional subset of CD8<sup>+</sup> T cells during chronic exhaustion is defined by SIRPα expressionLara M Myers, Michal Caspi Tal, Laughing Bear Torrez Dulgeroff, et al.
Science (New York, N.Y.)|September 21, 2023
Manipulating mitochondrial electron flow enhances tumor immunogenicityKailash Chandra Mangalhara, Siva Karthik Varanasi, Melissa A Johnson, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 15, 2011
Natural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8+ T-cell immunityPhilipp A Lang, Karl S Lang, Haifeng C Xu, et al.
Cell|February 10, 2015
Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetesRachel J Perry, João-Paulo G Camporez, Romy Kursawe, et al.
Cell Metabolism|January 4, 2023
Immunoediting instructs tumor metabolic reprogramming to support immune evasionChin-Hsien Tsai, Yu-Ming Chuang, Xiaoyun Li, et al.
Cancer Discovery|October 14, 2017
Impaired HLA Class I Antigen Processing and Presentation as a Mechanism of Acquired Resistance to Immune Checkpoint Inhibitors in Lung CancerScott Gettinger, Jungmin Choi, Katherine Hastings, et al.
Cell|September 10, 2019
Proteomics of Melanoma Response to Immunotherapy Reveals Mitochondrial DependenceMichal Harel, Rona Ortenberg, Siva Karthik Varanasi, et al.
Developmental Cell|November 11, 2021
1-deoxysphingolipids bind to COUP-TF to modulate lymphatic and cardiac cell developmentTing Wang, Zheng Wang, Lauriane de Fabritus, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 18, 2025
EVOLVE platform, a trispecific T cell engager with integrated CD2 costimulation, for the treatment of solid and hematologic tumorsOksana A Sergeeva, Guixian Jin, Mohosin Sarkar, et al.
Pageof 18